Archive | August, 2017

Just how big is the hepatitis C market in the United States?

This is a guest post from Rick Shalvoy, CEO, Consumer Health Education Programs The recent FDA approval of AbbVie’s Mavyret™  DAA (direct-acting antiviral) treatment for HCV (hepatitis C virus) has sparked any number of news stories about the beginning of a new “price war” between AbbVie and Gilead Sciences. Pharma business writers are all abuzz about the […]

Continue Reading

Drug Patent Expirations for Aug 31, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. RELPAX (eletriptan hydrobromide) Pfizer Ireland Patent number: 6,110,940 Expiration Date: Aug 29, 2017 DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs. For more information […]

Continue Reading

Drug Patent Expirations for Aug 24, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. SAXENDA (liraglutide recombinant) Novo Nordisk Inc Patent number: 7,235,627 Expiration Date: Aug 22, 2017 SAXENDA (liraglutide recombinant) Novo Nordisk Inc Patent number: 6,458,924 Expiration Date: Aug […]

Continue Reading

Drug Patent Expirations for Aug 17, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. ASMANEX TWISTHALER (mometasone furoate) Merck Sharp Dohme Patent number: 6,240,918 Expiration Date: Aug 20, 2017 DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs. For […]

Continue Reading